CYP2B6 and acute myeloid leukemia: Concerning leukemia, there are only two studies implicating the G516T CYP2B6 polymorphism in myeloid malignancies concerning 36 AML Turkey patients and 164 AML Chinese patients, respectively [22], [23]; no relevant study has been reported in European populations.